Regeneron Pharmaceuticals
The Regeneron Genetics Center seeks an individual contributor to analyze large-scale human genetic and phenotypic datasets for discovering therapeutic targets. This role involves integrating genetic data with multi-omics resources, applying advanced statistical methodologies, and collaborating with pre-clinical and clinical teams to validate potential treatments. Candidates will independently execute studies from conception to completion, requiring strong expertise in statistical genetics and programming.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Senior / Principal Scientist, Statistical Genetics
State of Indiana
Research Associate
McGill University
Director, Statistical Genetics
Bristol Myers Squibb
Causal and dynamic modeling of the human plasma proteome for target discovery
Amgen
Postdoctoral Research Fellow in Imaging Genetics
theuniversityoftexasataustin.com
Senior or Principal Scientist in Human Genetics
Digital Biology